Hjem › Type 2-diabetes › California › Los Angeles
Kliniske studier for Type 2-diabetes i Los Angeles, CA
16 studier for Type 2-diabetes søker deltakere på steder i og rundt Los Angeles (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
RekruttererFase 3
- Downtown LA Res Ctr. Inc., Los Angeles
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RekruttererFase 3
- Inglewood Clinical, Los Angeles
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RekruttererFase 3
- AURORA-2 Clinical Site, Los Angeles
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
RekruttererFase 2
- Los Angeles Institute for Metabolic Research, Los Angeles
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
RekruttererFase 2
- Los Angeles Institute for Metabolic Research, Los Angeles
- Velocity Clinical Research, Los Angeles, Los Angeles
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
RekruttererFase 3
- VAGLAHS Clinical Research Center (CRC), Los Angeles
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
RekruttererFase 3
- Research Site, Los Angeles
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
RekruttererFase 3
- Division of Endocrinology, Diabetes, and Metabolism, Los Angeles
- UCLA Mattel Children's Hospital, Los Angeles
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Rekrutterer
- University of Southern California, Los Angeles
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Rekrutterer
- University of Southern California, Los Angeles
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
RekruttererObservasjonsstudie
- Children's Hospital Los Angeles, Los Angeles
Type 2 Continuous Glucose Monitoring Academy
Rekrutterer
- Children's Hospital Los Angeles, Los Angeles
New T-UP: Engaging Vulnerable Students in Diabetes Prevention
Rekrutterer
- University of California, Los Angeles, Los Angeles
Implementation of Team Clinic for Type 2 Diabetes (TCT2)
Rekrutterer
- Children's Hospital Los Angeles, Los Angeles
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
Rekrutterer
- Angel City Research, Los Angeles
- Clemente Clinical Research, Los Angeles
DETERMINE: Detemir vs NPH
RekruttererFase 2
- University of California, Los Angeles, Los Angeles
Type 2-diabetes-studier i andre byer
- San Antonio, TX37 studier
- Houston, TX31 studier
- Orlando, FL25 studier
- Boston, MA20 studier
- Chicago, IL19 studier
- Dallas, TX19 studier
- Miami, FL19 studier
- Columbus, OH18 studier
- Las Vegas, NV18 studier
- San Diego, CA17 studier
- Atlanta, GA17 studier
- Birmingham, AL16 studier
Andre studier i Los Angeles
- Ikke-småcellet lungekreft87 studier
- Kreft (alle typer)74 studier
- Brystkreft73 studier
- Prostatakreft61 studier
- Kolorektal kreft59 studier
- Metastatisk kreft57 studier
- Eggstokkreft50 studier
- Lungekreft45 studier
- Plateepitelcancer i hode og hals42 studier
- Pankreaskreft35 studier
- Endometriekreft34 studier
- Melanom34 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.